FDA Adverse Event
Injury
Summary report: N
EGIA 60 ARTICULATING MED/THICK SULU
MDR report key: 2892204
·
Received December 21, 2012
Report
- Report Number
- 1219930-2012-01005
- Event Type
- Injury
- Date Received
- December 21, 2012
- Date of Event
- October 11, 2012
- Report Date
- November 27, 2012
- Manufacturer
- COVIDIEN LP, FORMERLY REGISTERED AS UNITED STATES
- Product Code
- GDW
- PMA / PMN Number
- K083519
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- RISK MANAGER
Narratives
Additional Manufacturer Narrative · 1
(B)(4).
Description of Event or Problem · 1
PROCEDURE TYPE: LAPAROSCOPIC GASTRIC BYPASS. ACCORDING TO THE REPORTER: STAPLE LINES WERE INSPECTED AND FOUND TO BE HEMOSTATIC ON (B)(6) 2012. ON (B)(6) 2012 THE PATIENT HAD TO BE RETURNED TO THE OPERATING ROOM DUE TO BLEEDING OVER THE STAPLE LINE THAT REQUIRED OVERSEWING. THE PATIENT REQUIRED AN ICU ADMISSION POST-OPERATIVELY AND SUSTAINED A RISE IN CREATINE LIKELY RELATED TO BLOOD LOSS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | EGIA 60 ARTICULATING MED/THICK SULU | NONE | GDW | COVIDIEN LP, FORMERLY REGISTERED AS UNITED STATES | N2E0753ULX |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 52 YR | Hospitalization| O |